Department of Cellular and Integrative Physiology Spring 2026 Seminar Series: Charles Nichols, PhD

The Department of Cellular and Integrative Physiology Spring 2026 Seminar Series welcomes Charles Nichols, PhD,

Professor with Tenure, LSU Health Sciences Center

Department of Pharmacology and Experimental

Therapeutics, New Orleans

Title: “Psychedelics as potential therapeutics for inflammaging”

Summary: Psychedelics acting at serotonin 5-HT2A receptors are potent anti-inflamamtories across several disease models. These including those for cardiovascular disease, diabetes, asthma, and rheumatoid arthritis in rodents. Further, psychedelics show potent anti-ROS and cellular protective effects in cellular models. Interestingly, all psychedelics are not equal in these effects, with some being more potent than others depending on the disease model